Publication
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial
Tjalf Ziemssen, Ovidiu A. Bajenaru, Adriana Carrá, Nina de Klippel, João Correia de Sá, Astrid Edland, Jette L. Frederiksen, Olivier Heinzlef, Klimentini E. Karageorgiou, Rafael H. Lander Delgado, Anne-Marie Landtblom, Miguel A. Macías Islas, Niall Tubridy, Yossi Gilgun-Sherki
Deutsche Zeitschrift für Nervenheilkunde, November 2014, Springer Science + Business Media
DOI: 10.1007/s00415-014-7565-7